arrow_back Back Filing freshness 10-Q Q3 FY2026 SEC EDGAR

Cavitation Technologies, Inc.

CVAT
Price unavailable
Materials ·Agricultural Services ·USAgricultural Services
77 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
17
Health
Poor
Bearish
auto_awesome

Analytical Summary

Cavitation Technologies, Inc. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap
Dividend Yield
Revenue Growth -97.5%
Op. Margin None
ROIC 57.6%
FCF / Share $-0.00
Trailing P/E
Price / Book
FCF Yield
Debt / Equity -0.32
info Valuation on last close.

77-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$3.00K
↓ -97.5%
Net Income Profit after all expenses
$-219.00K
↑ +4.8%
Operating Margin Operating profit as % of sales
-186.9%
↑ +52.5% 0th
FCF / Share Free cash flow per share
$-0.00
↑ +32.7%
Long-Term Debt Long-term obligations
$150.00K
— 0.0%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Debt to EquityDebt to Equity is concerning (bottom quartile)
  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
2
Returns
4
Financial Health
12
Cash Quality
97

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 19 years · 77 quarters